The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
Open accessAbstract
are not a homogenous entity and can be further subclassified into biologically relevant subgroups.A separation based on the proliferative index (Ki-67 >55%) was shown to have clinical implications regarding response to chemotherapy and prognosis: NEC with Ki-67 >55% responded better to platinum-based chemotherapy and, nevertheless, had a 4 months' shorter median survival than G3 NEN in the lower proliferative range (20-55%) [1] .More recent publications show that morphological differentiation and Ki-67 are able to separate prognostic groups among G3 cases, and therefore a separation of well-differentiated G3 NET from poorly differentiated G3 NEC is emerging [2][3][4] .The exact criteria need to be defined both on the morphological and on the molecular level.The spectrum of mutations of well-differentiated
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationNoda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationSorbye, H., Welin, S., Langer, S. W., Vestermark, L. W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds276 · Cited by 1,027
Self-citationMoertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Hanna, N., Bunn, P. A., Langer, C., Einhorn, L., Guthrie, T., Beck, T., Ansari, R., Ellis, P., Byrne, M., Morrison, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8595 · Cited by 681
Yachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J., DeMarzo, A. M., et al. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182417d36 · Cited by 534
Lara, P. N., Natale, R., Crowley, J., Lenz, H. J., Redman, M. W., Carleton, J. E., Jett, J., Langer, C. J., Kuebler, J. P., Dakhil, S. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1061 · Cited by 525
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Self-citationENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Self-citationBasturk, O., Yang, Z., Tang, L. H., Hruban, R. H., Adsay, V., McCall, C. M., Krasinskas, A. M., Jang, K.-T., Frankel, W. L., Balci, S., et al. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000408 · Cited by 482
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citationTNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Rindi, G., Falconi, M., Klersy, C., Albarello, L., Boninsegna, L., Buchler, M. W., Capella, C., Caplin, M., Couvelard, A., Doglioni, C., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs208 · Cited by 452
Self-citationNiederle, M. B., Hackl, M., Kaserer, K., & Niederle, B. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0152 · Cited by 444
Self-citationGastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J. A., Martínez del Prado, M. P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq022 · Cited by 419
Self-citationTang, L. H., Untch, B. R., Reidy, D. L., O'Reilly, E., Dhall, D., Jih, L., Basturk, O., Allen, P. J., & Klimstra, D. S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0548 · Cited by 352
Gastroenteropancreatic high‐grade neuroendocrine carcinoma
Sorbye, H., Strosberg, J., Baudin, E., Klimstra, D. S., & Yao, J. C. (2014) · Cancer · doi:10.1002/cncr.28721 · Cited by 347
Self-citationENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
Ramage, J. K., De Herder, W. W., Delle Fave, G., Ferolla, P., Ferone, D., Ito, T., Ruszniewski, P., Sundin, A., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443166 · Cited by 328
Self-citationPape, U.-F., Niederle, B., Costa, F., Gross, D., Kelestimur, F., Kianmanesh, R., Knigge, U., Öberg, K., Pavel, M., Perren, A., et al. (2016) · Neuroendocrinology · doi:10.1159/000443165 · Cited by 302
Self-citationWelin, S., Sorbye, H., Sebjornsen, S., Knappskog, S., Busch, C., & Öberg, K. (2011) · Cancer · doi:10.1002/cncr.26124 · Cited by 288
Self-citationBasturk, O., Tang, L., Hruban, R. H., Adsay, V., Yang, Z., Krasinskas, A. M., Vakiani, E., La Rosa, S., Jang, K.-T., Frankel, W. L., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000169 · Cited by 258
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J., Bidart, J., Cailleux, A., Bonacci, R., Ruffié, P., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.635 · Cited by 250
Self-citationBajetta, E., Catena, L., Procopio, G., De Dosso, S., Bichisao, E., Ferrari, L., Martinetti, A., Platania, M., Verzoni, E., Formisano, B., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0306-6 · Cited by 240
Yamaguchi, T., Machida, N., Morizane, C., Kasuga, A., Takahashi, H., Sudo, K., Nishina, T., Tobimatsu, K., Ishido, K., Furuse, J., et al. (2014) · Cancer Science · doi:10.1111/cas.12473 · Cited by 238
Hainsworth, J. D., Spigel, D. R., Litchy, S., & Greco, F. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0575 · Cited by 185
Iwasa, S., Morizane, C., Okusaka, T., Ueno, H., Ikeda, M., Kondo, S., Tanaka, T., Nakachi, K., Mitsunaga, S., Kojima, Y., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp173 · Cited by 170
Hentic, O., Hammel, P., Couvelard, A., Rebours, V, Zappa, M., Palazzo, M., Maire, F., Goujon, G., Gillet, A., Lévy, P., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0002 · Cited by 162
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
Hadoux, J., Malka, D., Planchard, D., Scoazec, J., Caramella, C., Guigay, J., Boige, V., Leboulleux, S., Burtin, P. C., Berdelou, A., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0075 · Cited by 147
Agaimy, A., Erlenbach‐Wünsch, K., Konukiewitz, B., Schmitt, A. M., Rieker, R. J., Vieth, M. W., Kiesewetter, F., Hartmann, A., Zamboni, G., Perren, A. A., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.40 · Cited by 130
Self-citationKorse, C. M., Taal, B. G., Vincent, A. D., van Velthuysen, M. F., Baas, P., Buning-Kager, J. C. G. M., Linders, T. C., & Bonfrèr, J. M. G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.012 · Cited by 122
Körner, M., Waser, B., Schönbrunn, A., Perren, A. A., & Reubi, J. C. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823d07f3 · Cited by 116
Self-citationImpact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
Ezziddin, S., Opitz, M., Attassi, M., Biermann, K., Sabet, A., Guhlke, S., Brockmann, H., Willinek, W. A., Wardelmann, E., Biersack, H., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1610-2 · Cited by 96
Brenner, B., Tang, L. H., Shia, J., Klimstra, D. S., & Kelsen, D. P. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.10.022 · Cited by 94
A Phase II Trial of Irinotecan and Cisplatin in Patients with Metastatic Neuroendocrine Tumors
Kulke, M. H., Wu, B., Ryan, D. P., Enzinger, P. C., Zhu, A. X., Clark, J. W., Earle, C. C., Michelini, A. L., & Fuchs, C. S. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-8001-3 · Cited by 90
Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas
Munhoz, R. R., Rêgo, J. F. M., Ferrari, A. R. D. C., Braghiroli, M. I., Bariani, G. M., Hoff, P. M., Costa, F. P., Pfiffer, T., & Riechelmann, R. P. (2013) · Rare Tumors · doi:10.4081/rt.2013.e39 · Cited by 22
Cited by
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Self-citationPavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Self-citationENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citation
Metadata
- Authors
- Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., Caplin, M., O''Toole, D., Perren, A., & participants, A. O. V. C. C.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 103
- Issue
- 2
- Pages
- 186-194
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2227093581
- Cited by
- 611
- References
- 37
- FWCI
- 44.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.